Synthesis and Evaluation of the Estrogen Receptor β–Selective Radioligand 2-18F-Fluoro-6-(6-Hydroxynaphthalen-2-yl)Pyridin-3-ol: Comparison with 16α-18F-Fluoro-17β-Estradiol-Reference-Cited by-同舟云学术

Synthesis and Evaluation of the Estrogen Receptor β–Selective Radioligand 2-18F-Fluoro-6-(6-Hydroxynaphthalen-2-yl)Pyridin-3-ol: Comparison with 16α-18F-Fluoro-17β-Estradiol

Published:2016-12-01 Issue:4 Volume:58 Page:554-559
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Antunes Inês F.,van Waarde Aren,Dierckx Rudi A.J.O,de Vries Elisabeth G.E.,Hospers Geke A.P.,de Vries Erik F.J.

Publisher

Society of Nuclear Medicine

Subject

Radiology Nuclear Medicine and imaging

Reference24 articles.

1. PET imaging of oestrogen receptors in patients with breast cancer

2. Estrogen receptor β ligands: Recent advances and biomedical applications

3. ERβ in breast cancer—Onlooker, passive player, or active protector?

4. Estrogen receptor β acts as a dominant regulator of estrogen signaling

5. The combination of letrozole and trastuzumab as first or second-line biological therapy produces durable responses in a subset of HER2 positive and ER positive advanced breast cancers

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiosynthesis and Preclinical Evaluation of 18F-Labeled Estradiol Derivatives with Different Lipophilicity for PET Imaging of Breast Cancer;Cancers;2024-07-24

2. Peering into the Brain’s Estrogen Receptors: PET Tracers for Visualization of Nuclear and Extranuclear Estrogen Receptors in Brain Disorders;Biomolecules;2023-09-18

3. Development of a Novel ¹⁸F-Labeled Probe for PET Imaging of Estrogen Receptor β;Journal of Medicinal Chemistry;2023-01-05

4. Nuclear Receptor Imaging In Vivo—Clinical and Research Advances;Journal of the Endocrine Society;2022-12-31

5. Positron emission tomography molecular imaging‐based cancer phenotyping;Cancer;2022-04-13